Necrotizing Soft-tissue Infections

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-18
Clinical Trial Update: Patients With Necrotizing Skin and Soft Tissue Infections Managed Within the SURFAST Care Pathway.
This clinical trial update indicates that the SURFAST care pathway study for necrotizing soft-tissue infections is not yet recruiting.